Smart Obesity Services in Maryland
Tirzepatide: A Double Approach to Diabetes and Weight Loss
Tirzepatide is a groundbreaking therapy gaining attention for treating type 2 diabetes and obesity. Unlike traditional drugs that target one pathway, tirzepatide uses two hormones, GLP-1 and GIP, to achieve a fuller metabolic control.
Published
Categorized as Diabetes Care, GLP1 agonist, Insights from Dr. Tashko, Tirzepatide Patient Information, Weight Loss
Muscle Loss and GLP-1 Agonists: What You Need to Know
While GLP-1 agonists offer exciting potential, some patients worry about their effects on muscle mass during weight loss. Let’s break down what’s happening in the body when using these medications, and how to protect your muscles.
Published
Categorized as GLP1 agonist, Insights from Dr. Tashko, Insulin Resistance, Muscle Physiology, Weight Loss